Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli

scientific article published in January 1995

Free secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1099/00222615-42-1-3
P698PubMed publication ID7739021
P5875ResearchGate publication ID15460211

P2093author name stringGiugliano LG
Ribeiro ST
Ulhoa CJ
Vainstein MH
P433issue1
P921main subjectEscherichia coliQ25419
P304page(s)3-9
P577publication date1995-01-01
P1433published inJournal of Medical MicrobiologyQ15708716
P1476titleFree secretory component and lactoferrin of human milk inhibit the adhesion of enterotoxigenic Escherichia coli
P478volume42

Reverse relations

cites work (P2860)
Q95328526Active free secretory component and secretory IgA in human milk: do maternal vaccination, allergy, infection, mode of delivery, nutrition and active lifestyle change their concentrations?
Q37651476Adhesion of Diarrheagenic Escherichia coli and Inhibition by Glycocompounds Engaged in the Mucosal Innate Immunity
Q35548772Anti-adhesion therapy of bacterial diseases: prospects and problems
Q34173786Bioactive factors in human milk
Q34666017Bovine lactoferrin decreases cholera-toxin-induced intestinal fluid accumulation in mice by ganglioside interaction
Q28137745Carbohydrate moieties in human secretory component
Q43806235Dietary bovine lactoferrin induces changes in immunity level and disease resistance in Asian catfish Clarias batrachus
Q37060544Effect of lactoferrin on enteric pathogens
Q45868649Expression of full-length bioactive antimicrobial human lactoferrin in potato plants
Q41959778Expression, purification and biochemical characterization of recombinant murine secretory component: a novel tool in mucosal immunology
Q41581938Factors that explain excretion of enteric pathogens by persons without diarrhea
Q40303575Glycans on secretory component participate in innate protection against mucosal pathogens
Q40444495Human Secretory IgM Antibodies Activate Human Complement and Offer Protection at Mucosal Surface
Q50075579Human milk glycoproteins inhibit the adherence of Salmonella typhimurium to HeLa cells
Q54521589Human secretory immunoglobulin A may contribute to biofilm formation in the gut.
Q21245322Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine
Q24803073In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins
Q36709727Induction of secretory immunity and memory at mucosal surfaces
Q24806554Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells
Q39671919Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis
Q37843732Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
Q33828704Mannose-containing oligosaccharides of non-specific human secretory immunoglobulin A mediate inhibition of Vibrio cholerae biofilm formation.
Q34650340Mini-review: Lactoferrin: a bioinspired, anti-biofilm therapeutic
Q35558518Mucosal Immune Development in Early Life: Setting the Stage
Q41682837Mucosal immunity in the female genital tract
Q44990753Multiple cleavage sites for polymeric immunoglobulin receptor
Q36943322Polymeric immunoglobulin receptor traffics through two distinct apically targeted pathways in primary lacrimal gland acinar cells.
Q40950183Recombinant expression of polymeric IgA: incorporation of J chain and secretory component of human origin
Q34508329Recombinant immunoglobulin A: powerful tools for fundamental and applied research
Q54376098Reduction of the amount of intestinal secretory IgA in fulminant hepatic failure.
Q40631760Release of Non‐Glycosylated Polymeric Immunoglobulin Receptor Protein
Q44791782Retinoic acid enhances the gene expression of human polymeric immunoglobulin receptor (pIgR) by TNF-alpha
Q35130615Role of secretory antibodies in the defence against infections
Q99711025Secretory IgA N-glycans contribute to the protection against E. coli O55 infection of germ-free piglets
Q33960542Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo
Q33347255Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces
Q34459044Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin
Q33784957The B-cell system of human mucosae and exocrine glands
Q41010889The human intestinal immune system: basic cellular and humoral mechanisms
Q38350313The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4.
Q77910460Thiol-disulfide redox buffers maintain a structure of immunoglobulin A that is essential for optimal in vitro binding to secretory component
Q26997004Treatment of microbial biofilms in the post-antibiotic era: prophylactic and therapeutic use of antimicrobial peptides and their design by bioinformatics tools

Search more.